ATE422555T1 - Test für niedrigmolekulares heparin, system und reagenz dafür - Google Patents

Test für niedrigmolekulares heparin, system und reagenz dafür

Info

Publication number
ATE422555T1
ATE422555T1 AT02784766T AT02784766T ATE422555T1 AT E422555 T1 ATE422555 T1 AT E422555T1 AT 02784766 T AT02784766 T AT 02784766T AT 02784766 T AT02784766 T AT 02784766T AT E422555 T1 ATE422555 T1 AT E422555T1
Authority
AT
Austria
Prior art keywords
reagent
low molecular
molecular heparin
heparin test
test
Prior art date
Application number
AT02784766T
Other languages
English (en)
Inventor
Patrick Mize
Original Assignee
Cardiovascular Diagnostics Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Cardiovascular Diagnostics Inc filed Critical Cardiovascular Diagnostics Inc
Application granted granted Critical
Publication of ATE422555T1 publication Critical patent/ATE422555T1/de

Links

Classifications

    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/86Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving blood coagulating time or factors, or their receptors
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/56Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving blood clotting factors, e.g. involving thrombin, thromboplastin, fibrinogen
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10STECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00Chemistry: molecular biology and microbiology
    • Y10S435/975Kit

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Hematology (AREA)
  • Molecular Biology (AREA)
  • Organic Chemistry (AREA)
  • Immunology (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • Urology & Nephrology (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Biomedical Technology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Biotechnology (AREA)
  • General Health & Medical Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pathology (AREA)
  • General Physics & Mathematics (AREA)
  • Medicinal Chemistry (AREA)
  • Food Science & Technology (AREA)
  • Cell Biology (AREA)
  • Neurosurgery (AREA)
  • General Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AT02784766T 2001-12-07 2002-12-09 Test für niedrigmolekulares heparin, system und reagenz dafür ATE422555T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US10/004,791 US6680177B2 (en) 2001-12-07 2001-12-07 Low molecular weight heparin assay, system and reagent therefor

Publications (1)

Publication Number Publication Date
ATE422555T1 true ATE422555T1 (de) 2009-02-15

Family

ID=21712538

Family Applications (1)

Application Number Title Priority Date Filing Date
AT02784766T ATE422555T1 (de) 2001-12-07 2002-12-09 Test für niedrigmolekulares heparin, system und reagenz dafür

Country Status (10)

Country Link
US (3) US6680177B2 (de)
EP (1) EP1451342B1 (de)
JP (1) JP4307264B2 (de)
AT (1) ATE422555T1 (de)
AU (1) AU2002346695A1 (de)
CA (1) CA2469458C (de)
DE (1) DE60231144D1 (de)
MX (1) MXPA04005518A (de)
TW (1) TW200307128A (de)
WO (1) WO2003050298A1 (de)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6680177B2 (en) * 2001-12-07 2004-01-20 Cardiovascular Diagnostics, Inc. Low molecular weight heparin assay, system and reagent therefor
US7572581B2 (en) * 2003-06-30 2009-08-11 Roche Molecular Systems, Inc. 2′-terminator nucleotide-related methods and systems
US7422905B2 (en) * 2004-02-27 2008-09-09 Medtronic, Inc. Blood coagulation test cartridge, system, and method
US7439069B2 (en) * 2004-02-27 2008-10-21 Nippoldt Douglas D Blood coagulation test cartridge, system, and method
US7399637B2 (en) * 2004-04-19 2008-07-15 Medtronic, Inc. Blood coagulation test cartridge, system, and method
WO2007095171A2 (en) * 2006-02-14 2007-08-23 Massachusetts Institute Of Technology Absorbing film
EP1918718A1 (de) 2006-10-31 2008-05-07 Roche Diagnostics GmbH Verfahren und Vorrichtungen zur elektrochemischen Bestimmung von Faktor Xa-Inhibitoren in Blutproben
BRPI0720361A8 (pt) * 2006-12-19 2015-10-13 Koninklijke Philips Electronics Nv Método para medir aglutinação de uma ou mais partículas em um ensaio de aglutinação induzida por alvo efetuado em uma câmara de reação, e, kit e dispositivo para medir um ou mais parâmetros de aglutinação de partículas em um ensaio de aglutinação induzida por alvo
WO2014041508A1 (en) * 2012-09-12 2014-03-20 Biocant - Centro De Inovação Em Biotecnologia Antimicrobial coating compositions

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5110727A (en) * 1987-04-03 1992-05-05 Cardiovascular Diagnostics, Inc. Method for performing coagulation assays accurately, rapidly and simply, using dry chemical reagents and paramagnetic particles
US4849340A (en) 1987-04-03 1989-07-18 Cardiovascular Diagnostics, Inc. Reaction system element and method for performing prothrombin time assay
TW221493B (de) 1990-07-10 1994-03-01 Cardiovascular Diagnostics Inc
EP0509086B1 (de) * 1990-11-05 1995-04-12 Dade Produktions AG Verfahren zur bestimmung der konzentration von antikoagulantien
US5474765A (en) * 1992-03-23 1995-12-12 Ut Sw Medical Ctr At Dallas Preparation and use of steroid-polyanionic polymer-based conjugates targeted to vascular endothelial cells
US5568723A (en) * 1992-09-08 1996-10-29 Olin Corporation Long life catalytic gas generator for space propulsion applications
EP0685069A4 (de) 1993-02-17 2002-01-23 Cardiovascular Diagnostics Inc Immunoassay und affinitätstest auf der grundlage einer trockenchemischen kaskade
US5670329A (en) 1993-05-28 1997-09-23 Cardiovascular Diagnostics, Inc. Method and analytical system for performing fibrinogen assays accurately, rapidly and simply using a rotating magnetic field
WO1999010746A2 (en) * 1997-08-26 1999-03-04 The University Of North Carolina At Chapel Hill Method of monitoring blood low molecular weight heparin and heparin
US6165795A (en) 1998-06-25 2000-12-26 Cardiovascular Diagnostics, Inc. Methods for performing fibrinogen assays using dry chemical reagents containing ecarin and magnetic particles
US6200532B1 (en) * 1998-11-20 2001-03-13 Akzo Nobel Nv Devices and method for performing blood coagulation assays by piezoelectric sensing
WO2001044493A2 (en) 1999-12-15 2001-06-21 Pentapharm Ag Hematological assay and reagent
CA2408850A1 (en) * 2000-05-09 2001-11-15 Pharmanetics Incorporated Platelet function assay and reagent therefor
US6680177B2 (en) * 2001-12-07 2004-01-20 Cardiovascular Diagnostics, Inc. Low molecular weight heparin assay, system and reagent therefor

Also Published As

Publication number Publication date
AU2002346695A1 (en) 2003-06-23
CA2469458C (en) 2011-02-01
US20070111271A1 (en) 2007-05-17
US20040115753A1 (en) 2004-06-17
US20030124638A1 (en) 2003-07-03
WO2003050298A1 (en) 2003-06-19
DE60231144D1 (de) 2009-03-26
JP4307264B2 (ja) 2009-08-05
JP2005513424A (ja) 2005-05-12
EP1451342B1 (de) 2009-02-11
EP1451342A1 (de) 2004-09-01
US6680177B2 (en) 2004-01-20
TW200307128A (en) 2003-12-01
EP1451342A4 (de) 2005-06-15
CA2469458A1 (en) 2003-06-19
MXPA04005518A (es) 2005-04-19

Similar Documents

Publication Publication Date Title
ATE417125T1 (de) Diagnose von einer klinischen infektion einer wunde
WO2004093641A3 (en) Acoustic blood analyzer for assessing blood properties
MXPA03009111A (es) Sistema de medicion biologica.
TWI256975B (en) Compositions containing a urea derivative dye for detecting an analyte and methods for using the same
DE69433691D1 (de) Vorrichtung zur feststellung von viskositätsänderungen in fluidproben, sowie ein verfahren dazu
DE60024669D1 (de) Hämatologische bestimmung und reagenz
DE69832628D1 (de) Rekombinant-kaninchengewebefaktor basiertes prothrombinzeitreagenz
ATE406834T1 (de) System zur überwachung der konzentration von analyten in körperflüssigkeiten
ATE422555T1 (de) Test für niedrigmolekulares heparin, system und reagenz dafür
DE50104561D1 (de) Verfahren zur Diagnose von Sepsis unter Bestimmung löslicher Cytokeratinfragmente
ATE437960T1 (de) Hämatologisches bestimmungsverfahren und kit
DE68912115D1 (de) Ausscheidungsverfahren für die herstellung von thromboplastinreagenzien.
DE50101520D1 (de) Kompetitives assay-verfahren
HUP0500620A2 (hu) Oldható fibrin vizsgálatára szolgáló eljárás
DE60230988D1 (de) Proteine in der diabetes-proteomanalyse
DE60334408D1 (de) Nsäuren
DK0570355T3 (da) Anvendelse af prothrombin-fragmenter
DE50203415D1 (de) Verfahren zur vorhersage eines transplantatabstossungsrisikos und immunologischer testkit
DE69912453D1 (de) Verfahren und materialien zur diagnose instabiler angina
ATE208504T1 (de) Komplex-gebundene hemmstoffe aktivierbarer stoffwechselenzyme als molekulare marker zur diagnostik und therapieüberwachung
DK1407266T3 (da) Fremgangsmåde til estimering af mængden af specifikke neutrofile celletyper
ATE297410T1 (de) Lupus antikoagulant-antikörper gegen die f1 region von prothrombin
ATE119291T1 (de) Verfahren zur bestimmung von antikörpern gegen erreger von infektionskrankheiten in körperflüssigkeiten, mittel dazu und ihre verwendung in diesem verfahren.
Hawkins et al. Extraction methods for preparing thromboplastin reagents
WO2003005033A8 (en) Carcinoma-related peptides

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties